Ashfield US is delighted to announce the appointment of two new Vice Presidents of Business Development, Scott Neff and Jennifer Garofolo. As part of the company’s ambitious growth journey, the appointments have been made as part of the commitment to provide clients with creative, scalable and tailored health solutions that deliver positive outcomes for patients and add value for clients.
In recent years, Ashfield’s growth journey in the US has been exponential as they continue to grow their services across Commercial, Patient Solutions, Medical Affairs, Advisory and Healthcare Communications. This growth journey is set to continue within the Commercial and Patient Solutions Business Unit in the US with the provision of high quality, agile services including contract sales teams, customer service reps, medical science liaison officers, remote detailing, clinical educators, medical information, market access and pharmacovigilance.
Jennifer joins Ashfield after nearly twenty years at Johnson & Johnson, her most recent role being Group Product Director. Jennifer brings with her an immense knowledge of sales and marketing as well as Payer/access, leadership, coaching and oncology, haematology, CV, and neuroscience expertise.
Scott brings over thirty years of pharmaceutical and healthcare sales experience to Ashfield. Most recently, Scott served as Vice President, Business Development at Bioclinica. Scott has a proven record of accomplishment, leading sales teams and initiatives that expand across a broad platform of needs for Biotech and Pharmaceutical companies.
“We look forward to the addition of both Scott and Jennifer and believe that with their strong tenure in the industry we can create great opportunities to partner with clients to improve lives by helping healthcare professionals and patients get the medicines, knowledge and support they need” comments Greg Flynn, Regional President, Ashfield US.